Hyaluronic Acid Degradation Products Research Articles

Characterization of a Hyaluronidase-Producing Bacillus sp. CQMU-D Isolated from Soil.

Hyaluronidase (HAase) can depolymerize mucopolysaccharide hyaluronic acid (HA) to increase the efficacy of drug diffusion in the case of pathogenic bacteria. Due to its widespread medical applications, HAase originating from microorganisms has attracted significant attention. In this study, the HAase-producing bacterium Bacillus sp. CQMU-D was isolated from soil and identified based on its morphology and 16S rRNA gene sequencing. Enzyme activity was detected by measuring the content of reducing sugar in HA degradation products with 3,5-dinitrosalicylic acid (DNSA) or p-dimethylaminobenzaldehyde (DMAB) as the detection reagent. The results revealed that HAase reached maximum activity after 48h of cultivation. Gene function annotation after full-length sequencing showed increased transport and metabolic activities associated with HAase. Additionally, the HAase gene of Bacillus sp. CQMU-D was different from the existing microbial HAase, and its protein was predicted to be a stable secretory protein with a conserved GAG_Lyase domain. These results characterized a new HAase-producing Bacillus from the soil via enzyme activity and bioinformatic analysis, expanding the knowledge on Bacillus HAase for potential industrial applications.

Hyaluronidase modulates bleomycin‐induced lung injury detected noninvasively in small rodents by radial proton MRI

To assess whether hyaluronic acid, a building block of proteoglycans and extracellular matrix with hydrophilic characteristics, might contribute to magnetic resonance imaging (MRI)-detected proton signals elicited by bleomycin in the lung. To this end, hyaluronidase, which degrades hyaluronic acid, was administered to bleomycin-challenged animals. Fibrosis was induced by oropharyngeal aspiration (OA) of bleomycin. Mice received bleomycin once daily (0.1 mg/kg) on 6 consecutive days, while rats were given a single dose (2 or 4 mg/kg). Hyaluronidase, budesonide, and the respective vehicles were also administered via OA. Animals were examined using a radial ultrashort echo time sequence. Histology of picrosirius reflecting collagen and tissue gene analysis were performed postmortem. In mice, hyaluronidase induced an increase of high intensity signals by 34 ± 12 μL (means ± SD, P = 0.007), consistent with the ability of the degradation products of hyaluronic acid to provoke acute inflammation. Budesonide was able to resolve hyaluronidase-induced signals or to prevent their formation. Combined administration of budesonide and hyaluronidase to bleomycin-treated rats resulted in an overall decrease (-17.1 ± 7%, P = 0.02) of the MRI-detected bleomycin-induced signals. Moreover, the relative gene expression of hyaluronidase was reduced (-61.8 ± 10.2%, P < 0.001) in fibrotic lungs. The present data indicate that hyaluronic acid contributes to the bleomycin-induced responses detected by MRI in the lung.

Snake venom hyaluronidase: a therapeutic target

The diffusion of toxins from the site of a bite into the circulation is essential for successful envenomation. Degradation of hyaluronic acid in the extracellular matrix (ECM) by venom hyaluronidase is a key factor in this diffusion. Hyaluronidase not only increases the potency of other toxins but also damages the local tissue. In spite of its important role, little attention has been paid to this enzyme. Hyaluronidase exists in various isoforms and generates a wide range of hyaluronic acid degradation products. This suggests that beyond its role as a spreading factor venom hyaluronidase deserves to be explored as a possible therapeutic target for inhibiting the systemic distribution of venom and also for minimizing local tissue destruction at the site of the bite.

Crosslinked hyaluronan scaffolds as a biologically active carrier for valvular interstitial cells

Hyaluronic acid (HA), a major component of the cardiac jelly during heart morphogenesis, is a polysaccharide that upon modification can be photopolymerized into hydrogels. Previous work in our lab has found that photopolymerizable HA hydrogels are suitable scaffolds for the culture and proliferation of valvular interstitial cells (VICs), the most prevalent cell type in native heart valves. The physical properties of HA gels are easily modified through alteration in material crosslink density or by copolymerizing with other reactive macromolecules. Degradation products of HA gels and the starting macromers significantly increased VIC proliferation when added to cell cultures. With low molecular weight HA (<6700 Da) exhibiting greatest stimulation of VIC proliferation. Low molecular weight HA degradation products added to VIC cultures also resulted in a four-fold increase in total matrix production and a two-fold increase in elastin production over untreated controls. VIC internalization of HA, as shown by cellular uptake of fluorescently labeled HA, likely activates signaling cascades resulting in the biological responses seen here. Lastly, VICs encapsulated within HA hydrogels remained viable, and significant elastin production was observed after 6 weeks of culture. This work shows promise for the creation of a tissue-engineered heart valve utilizing the synergistic relationship between hyaluronic acid and VICs.

Hyaluronectin blocks the stimulatory effect of hyaluronan-derived fragments on endothelial cells during angiogenesis in vitro

Hyaluronic acid (HA) is a glycosaminoglycan of the extracellular matrix. Its fragmentation by the hyaluronidase, secreted by tumor cells, facilitates tumor invasion and the HA degradation products generated stimulate angiogenesis. We report here that the HA-binding protein hyaluronectin (HN) inhibits the stimulatory effect of HA-derived fragments on the proliferation and migration of endothelial cells in vitro, and hampers the organization of endothelial cells into capillary-like structures. Since HN strongly inhibits endothelial cell adhesion to immobilized HA, it is postulated that HN acts by impairing the binding to endothelial cells of HA fragments generated by hyaluronidase, thereby neutralizing the effect of HA degradation products on angiogenesis. Our results reveal a new mechanism by which the angiogenesis induced by HA fragments is modulated by HN.

Hyaluronic acid degradation products induce neovascularization and fibroplasia in fetal rabbit wounds

Scarless fetal wound healing occurs with mild fibroplasia and neovascularization, while the wound is persistently enriched with hyaluronic acid. Conversely, adult wounds are characterized by prominent fibroplasia, neovascularization, and scar formation, and hyaluronic acid is a transient component of the early adult wound matrix. Our group has reported that enzymatic degradation of fetal rabbit wound hyaluronic acid results in marked increases in fibroplasia, collagen deposition, and neovascularization. This altered, adultlike healing response is hypothesized to have resulted from the generation of biologically active hyaluronic acid degradation products. Therefore, this study analyzes the fibrovascular inductive activity of hyaluronic acid degradation products. Fetal rabbit wounds were treated with hyaluronic acid degradation products generated by methods known to produce oligosaccharides with significant angiogenic activity. Implants from wounds treated with either of the control solutions (n = 4 for each control) had identical histologic features characterized by a mild mononuclear cell infiltrate but neither infiltrating fibroblasts nor collagen. In marked contrast, implants from wounds treated with hyaluronic acid degradation products contained infiltrating fibroblasts and collagen intermixed with numerous blood vessels. Quantitation of capillary ingrowth showed a sixfold increase in the neovascular response in wounds treated with hyaluronic acid degradation products compared with either controls (p < 0.05). This study shows that hyaluronic acid degradation products stimulate neovascularization and fibroplasia in fetal wounds. These observations suggest that a balance between hyaluronic acid accumulation and degradation has significant regulatory influence in fetal tissue repair.

Evidence for steroid control of a putative angiogenic factor in the porcine uterus

The formation of new capillaries, both in extraembryonic membranes and in the maternal endometrium, is an essential prerequisite for appropriate feto-maternal relationships throughout pregnancy. At present there is no indication of the nature of the uterine angiogenic stimulus. In-vitro, degradation products of hyaluronic acid, following its catalysis by hyaluronidase, have been shown to have angiogenic properties. In the current study, levels of hyaluronic acid in endometrial tissues and of hyaluronidase and hyaluronic acid in uterine flushings were measured during the oestrous cycle and early pregnancy. The concentration of both hyaluronic acid and hyaluronidase in uterine flushings followed the growth and regression of the corpus luteum, in that basal levels detected on days 0 and 6 increased to peak concentrations on days 12 and 15. By day 18, levels of both hyaluronidase and hyaluronic acid had decreased in cyclic gilts, but remained increased in pregnant pigs. Tissue concentrations of hyaluronic acid were not affected by pregnancy or by the day of the oestrous cycle. In a subsequent experiment, four groups of gilts were ovariectomized on day 4 and thereafter received daily injections of corn oil, progesterone, oestrogen or a combination of oestrogen and progesterone. Hyaluronidase was undetectable in uterine flushings collected on day 15 from corn oil- and oestrogen-treated gilts, but present in similar amounts in uterine flushings from gilts treated with progesterone and progesterone plus oestrogen. Similarly, uterine fluid concentrations of hyaluronic acid were increased in progesterone- and progesterone plus oestrogen-treated gilts, but not in corn oil- or oestrogen-treated pigs. Tissue concentrations of hyaluronic acid were unaffected by steroid treatment.(ABSTRACT TRUNCATED AT 250 WORDS)

Angiogenesis Induced by Degradation Products of Hyaluronic Acid

Partial degradation products of sodium hyaluronate produced by the action of testicular hyaluronidase induced an angiogenic response (formation of new blood vessels) on the chick chorioallantoic membrane. Neither macromolecular hyaluronate nor exhaustively digested material had any angiogenic potential. Fractionation of the digestion products established that the activity was restricted to hyaluronate fragments between 4 and 25 disaccharides in length.

Peritoneal Dialysis Solutions

Peritoneal dialysis solutions are specially formulated for use during and immediately after an episode of peritonitis. The solutions include one or more additives to minimize the injury and physiological effects that peritonitis can cause. One additive is a mixture of amino acids sufficient to maintain a positive nitrogen balance, at least one of the amino acids being present in a dipeptide form. Another additive is a compound that scavenges free radicals generated by peritoneal macrophages activated by the peritonitis. Another additive is chondroitin sulfate that changes the permeability of the peritoneal membrane during subsequent dialysis using solutions free of chondroitin sulfate. Another additive is the degradation products of hyaluronic acid to enhance the regeneration of the peritoneal mesothelium without fibrosis.

Quantitative analysis of hyaluronic acid by high-performance liquid chromatography of streptomyces hyalu-ronidase digests

The separation and quantitative analysis of streptomyces hyaluronidase (HAase) degradation products of hyaluronic acid (HA) by high-performance liquid chromatography are described. The substituted 4,5-unsaturated tetrasaccharide and hexasaccharide which result from the digestion of HA are quickly separated on a silica gel (Zorbax SIL) column. The assay of HA is linear between 5 and 250 μg of HA. This procedure is suitable for some weakly acidic glycosaminoglycan contaminants having similar properties to those of HA.

Mode of Action of Two Spreading Factors of Testicular and Bacterial Origin

The degradation products of hyaluronic acid and sodium chondroitin sulphate by testicular and bacterial spreading factors were analyzed simultaneously by paper chromatography and reductimetry; then by spectrophotometry. The products obtained were found to be different qualitatively and quantitatively, thus confirming a different mode of action. The bacterial enzyme produced unsaturated disaccharides with hyaluronic acid while more polymerized compounds were obtained with testicular enzyme on both substrates.